天弘创新药精选50ETF联接A(014564)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
951,193.47 |
23,749.46 |
37,904.02 |
26,876.77 |
| 存出保证金 |
170,266.31 |
108,351.81 |
13,329.81 |
20,546.58 |
| 交易性金融资产 |
715,200,813.75 |
275,757,555.57 |
62,540,492.79 |
57,714,553.17 |
| 其中：股票投资 |
8,113,402.79 |
11,455,099.45 |
1,360,990.30 |
1,859,431.01 |
| 债券投资 |
7,042,210.96 |
1,004,407.40 |
101,263.40 |
407,276.16 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
9,800,204.60 |
- |
442,642.41 |
568,987.95 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
5,268,082.40 |
20,846,093.24 |
119,271.60 |
310,699.21 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
772,937,271.01 |
315,522,616.87 |
66,577,717.99 |
61,897,136.46 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
18,739,947.01 |
0.24 |
0.11 |
| 应付赎回款 |
26,955,334.27 |
6,819,042.86 |
670,027.81 |
1,447,112.46 |
| 应付管理人报酬 |
25,914.18 |
6,664.46 |
1,759.47 |
2,225.77 |
| 应付托管费 |
5,182.84 |
1,332.89 |
351.89 |
445.17 |
| 应付销售服务费 |
102,455.49 |
12,998.44 |
9,166.04 |
9,219.96 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
156,523.78 |
66,630.83 |
121,470.15 |
70,342.75 |
| 负债合计 |
27,245,410.56 |
25,646,616.49 |
802,775.60 |
1,529,346.22 |
| 所有者权益 |
| 实收基金 |
656,482,794.45 |
281,890,655.63 |
81,217,905.57 |
89,994,516.89 |
| 未分配利润 |
89,209,066.00 |
7,985,344.75 |
-15,442,963.18 |
-29,626,726.65 |
| 所有者权益合计 |
745,691,860.45 |
289,876,000.38 |
65,774,942.39 |
60,367,790.24 |
| 负债及所有者权益总计 |
772,937,271.01 |
315,522,616.87 |
66,577,717.99 |
61,897,136.46 |
微信公众号
证券之星APP
基本资料
